← SynDRA
SIMUROSERTIB
SynDRA canonical compound SYN0039734 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CDC7 |
| Mechanism of action | kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- CDC7 INHIBITOR
- Cell division cycle 7-related protein kinase inhibitor
- kinase inhibitor
Cross-references
Synonyms
- TAK-931
- TAK931F
- XGVXKJKTISMIOW-ZDUSSCGKSA-N
- UNII-LST350G3XU
- LST350G3XU
- SCHEMBL19410618
- SCHEMBL12459022
- EX-A2702
- HY-100888
- CS-0020550
- Thieno(3,2-d)pyrimidin-4(3H)-one, 2-(2S)-1-azabicyclo(2.2.2)oct-2-yl-6-(3-methyl-1H-pyrazol-4-yl)-
- 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4 (3H)-one
- Tak 931
- simurosertibum
- RefChem:183134
- Cell Division Cycle 7 Inhibitor TAK-931
- Simurosertib [USAN]
- WHO 11008
- TAK931
- Simurosertib (USAN/INN)
- SIMUROSERTIB [INN]
- Simurosertib (TAK-931)?
- SIMUROSERTIB [WHO-DD]
- orb1309184
- GTPL10317
- CHEBI:233316
- GLXC-20157
- BDBM50506350
- MFCD30802281
- ZB1533
- AKOS040736357
- example 108 [US9655900B2]
- AC-36305
- MS-25218
- D12176
- F90328
- T013409
- O1V
- SCHEMBL23521052
Look up SIMUROSERTIB in the interactive SynDRA portal →